Delivering Value and Optimal Outcomes
As life sciences entities work to trans-form from selling medicines to managing outcomes, North Highland is ready to help.
We work with nine of the world’s top life sciences companies to help them transform for the future: from enabling blockbuster launches to delivering personalized medicines; from science-based R&D processes to patient-centric development; from traditional to multichannel marketing. By working throughout the research – delivery continuum, North Highland provides the depth and breadth of experience and perspective needed to deliver outcomes-driven operational excellence.
Clinical Trial Transformation
Today, legacy operating models fall woe-fully short in the increasingly complex clinical trial landscape. North Highland works with clients to incorporate flexibil-ity, agility and innovation into R&D opera-tions, to get safe drugs to patients faster and less expensively.
The Experience Era, where nothing – not price, not quality – is more important than the experience companies provide, is impacting all aspects of life sciences operations. By putting the patient at the center of operations, especially those related to drug development and clinic trials, North Highland helps our clients improve outcomes and the patient experience.
Clinical Data Standards
Smart life sciences organizations don’t just implement compliance-driven stop gaps to meet expanding data standards and submission guidelines. They take a more strategic, future-ready approach. And North Highland shows them how, by helping develop and implement end-to-end data systems that enable higher quality, less expensive and completely compliant clinical development processes.
Amidst increasing demand, growing public pressure, and uncertain legal and regulatory requirements, life sciences organizations must figure out how to provide expanded pre- and post-approval access to patients who need it most.
North Highland helps clients develop holistic programs that account for the complex strategic, operational and technological factors necessary to safely and ethically meet the needs of the most desperate patients. The end result is an operational excellence strategy for expanded access, achieved with ethics and patient safety at the core.
Despite internal and external pressures to accelerate multi-channel marketing, progress among life sciences organizations has been slowed by a complex regulatory environment, rapidly shifting customer expectations, and not-yet mature digital operations. North Highland speeds progress with processes and technologies that empower organizations to engage with customers when, how and where they are most likely to convert.
Smarter Drug Development
While today is an exciting time for the biopharma industry in terms of scientific innovation (e.g. immuno-oncology, targeted therapies, RNAi, stem cells), growing R&D pipelines, and the increasing number of FDA approvals, a consistent challenge remains – the rigorous and costly clinical development effort required to bring a new product to market.
Changing the Conversation - Case Study
Bob Pietrobono explains how life sciences companies are working to change lives through the way they interact with their patients and healthcare providers. By combining members from our change management, marketing, and other industry backgrounds, we were able to help this life sciences company get the right information to the right individuals at the right time.
Improve Clinical Trial Outcomes by Boosting Patient Experience
Companies should build a patient-centricity program on a central foundation of providing a world-class patient experience. This requires a shift away from the traditional classification of trial participants as “subjects” who serve as a means for data collection towards one that considers participants as “customers.”
"I was looking for a consulting partner with deep expertise in planning and driving complex projects. North Highland provided highly experienced consultants who leveraged our internal framework, developed insightful and practical solutions for our projects, and helped myself and our internal team members build our own skills in managing and driving change going forward."
Executive Director, IT Global Pharmaceutical Company
Bob joins North Highland after 25+ years in management consulting and the software industry. Bob started his career with Andersen Consulting and was a Partner/Principal with both Deloitte Consulting and Ernst & Young. Bob was instrumental in forming Andersen’s Life Sciences practice and led business development and delivery efforts at both Deloitte and Ernst & Young. His specific area of expertise is leading complex transformation programs and has done so for Astra/Merck, BMS, Merck, Boston Scientific, Becton Dickinson and AmerisourceBergen.
Peter has twenty-five years of proven Operating Model Transformation, Or-ganizational Change Management and Organizational Development expe-rience with Life Sciences clients, run-ning projects, engaging stakeholders and fostering consensus to achieve business goals. He has particular skills in enabling executives to manage complex multi-stakeholder projects, navigate conflicting agendas; and en-gender broad-based organizational consensus on best-fit actions and re-sults.